Introduction
Worldwide, it is reported that cervical cancer is the second most common and the fifth deadliest disease in women. It affects about 16 per 100,000 women per year and kills about 9 per 100,000 per year. Approximately, 80% of cervical cancer occur in developing countries . Globally, in 2008, it was estimated that there were 473,000 cases of cervical cancer, and 253,500 deaths per year (Dim, 2012) . According to a report of Alliance for Cervical Cancer Prevention (ACCP) (2004), the regions hardest hit by cervical cancer are among the worlds poorest regions which are in Central and South America, the Caribbean, sub-Saharan Africa and parts of Asia. Ferley, Bray, Pisani and Parkin (2013) earlier stated that approximately 1.4 million women worldwide are living with cervical cancer, up to 7 million women worldwide may have precancerous condition that needs to be identified and treated early. Recent years have witnessed a significant development in cervical cancer prevention in developed countries in addition to cytology screening services. Previous efforts to implement cytology-based screening in developing countries have been conducted in the early 1980's but it has failed to reduce the mortality rates, mainly due to inadequate material resources, and lack of trained providers. In this regard, a recent cost-effective screening strategy using VIA emerged to be use, in developing countries like Nigeria.
Ibrahim, Rasch, Pukkala and Aro (2004) reported that cervical cancer screening based on cytological examination is largely unavailable in developing countries or available only to a small, select group of women in private facilities, maternal and child health sites, or family planning clinics, thereby missing the age groups at the highest risk for precancerous lesions. According to Evaluation of Cervical Cancer in Nigeria (2013), the failure of a conventional cytology-based approach to reducing cervical cancer in developing countries, particularly in Africa, can be attributed to several factors including scarcity of trained skilled professionals, lack of resources and expense. Therefore, an interest in a new screening method using visual techniques to identify cervical cancer developed. The technique involved is the simple screening method, that is visual screening by use of acetic acid (VIA), during which the cervix is visualized with the naked eye under a direct source of light and application of a solution of 3% -5% acetic and that is used as a chemical contrast agent to highlight areas of metaplastic changes is a malignant change in the aceto-white area in the cervix, which is precisely around the squamo-columnar junction, the main anatomical site where cervical malignant neoplasia develops.
USAID (2010) stated that the choice of screening test usually depends on the resources available. Many developing countries are now using the single visit approach which combines detection of lesions using visual inspection with acetic acid (ordinary vinegar) followed by immediate treatment if necessary. Gaffikin, Mcgrath, Arbyn, Blumenthal (2007) stated that cervical cancer, the second most commonly diagnosed cancer among women worldwide, can be a preventable disease. Although the pap smear remains the most common screening test for cervical cancer, many developing countries may not have adequate resources to implement cytology-based prevention programmes. An alternative, low-cost test, visual inspection using acetic acid (VIA), has emerged for use in developing countries, Nigeria inclusive where the resources may or may not be available. Gupta(2011) stated that the cost factor on testing for human papilloma virus (HPV) using DNA testing, coupled with requirement of trained manpower makes the option non-viable for developing countries, thus, accentuating the need for alternative screening procedures. Visual inspection using acetic acid (VIA) has emerged as a promising cost-effective, non-cytology-based, 'see and treat' alternative for economically developing geographic regions where it is available. Globally, decrease uptake of cervical cancer screening is predominantly a problem of developing countries, due to limited access to screening facilities, thereby leading to the high increased in the number of women who come up with cervical cancer. The extent to which the number of women diagnosed with cervical cancer keep on increasing has remained a matter of grave concern to the present researchers that a study on availability of Visual Inspection With Acetic Acid (VIA) requirements in the secondary healthcare institutions of Kaduna -state is therefore considered desirable with a view to increase the deliverance of screening programmes and subsequently the decline of cervical cancer.
II.

Hypothesis
A null-hypothesis is stated below stating that:
There is no significant difference among the secondary healthcare institutions in the provision of available VIA requirements for cervical cancer screening in Kaduna State.
III. Methods
A cross-sectional survey design was used for the study. The research population comprises of all Nurses working in secondary healthcare institutions of Kaduna state. According to the State Ministry of Health (2013), the distribution of Nurses working in the secondary healthcare institutions of the state are 1,081. The use of nurses for this study is justified by the fact that the innovation of VIA is to increase the up-take of cervical cancer screening in developing countries, at primary and secondary health care institutions, also nursing staff have the highest percentage of workers among the health workers of Kaduna-state, they monitor the condition of patients for 24hours and are therefore in a better position to respond to questions that will be raise on availability of VIA requirements to screen for cervical cancer. The sample size used was 300 based on Yamane, (1967) sample size formula. A stratified sampling was used to select the existing senatorial zones of Kaduna, into northern, central and southern zones. Each stratum of the senatorial zone served as clustered according to the present existing local government areas.
A purposive sampling was used to select nine (9) local government areas (Kaduna-South, KadunaNorth,Birnin-Gwari, Ikara, Zaria, Sabon-Gari, Kauru, Jama'a and Kachi'a) that have secondary healthcare institutions. As such, the purposely selected secondary healthcare institutions were (Barau Dikko specialist hospital, Yusuf Dantsoho memorial hospital, Jibril mai-gwari memorial hospital, General hospital Ikara, Gambo-Sawaba memorial hospital Zaria, Major Ibrahim memorial hospital Sabon-Gari, General hospital Kachia) served as the sampling frame from which the sample of 300 nurses was drawn. Proportionate sampling was used at the secondary healthcare institutions to distribute questionnaires to the health workers based on their number in each hospital (see table 4 below). The health workers available were given copies of the questionnaire to fill at the selected secondary healthcare institutions, this was employ because the researchers can easily reach out to the respondents at their various work locations. Questionnaire designed by the researchers was the instrument used for data collection. The responses to the items of the questionnaire were measured on a four point interval scale. The scale was patterned along Likert format of Strongly Agree (SA) = 4, Agree (A) = 3, Disagree (D) = 2, and Strongly Disagree ( SD) = 1. The filled questionnaire copies were retrieved from the health workers at the various selected secondary healthcare institutions by the researcher/ assistant after two weeks of administration. The data collected were analyzed using descriptive statistics of means and standard deviations. In the test of the hypothesis stated, one-way analysis of variance (ANOVA) was used.
IV. Results
The data analysis involves the use of means and standard deviations; this was based on the interval scale of measurement which quantified the data collected. Conclusion of the items was based on the mid-point along the four points interval scale. The mid-point used in the study is 2.5, the value (2.5) stands for the least level of agreement on the scale while aggregate mean lower than 2.5 could thus be regarded as disagreement. The research hypothesis involved in the study was tested and analyzed with one-way analysis of variance (ANOVA) at 0.05 level of significance. Table 1 , showed an aggregate mean of 2.1458 which is less than the decisive mean of 2.5.Thus it indicates that VIA requirements are not available in secondary healthcare institution of kaduna state to screen for cervical cancer. (F-Critical = 2.37, p< 0.05) Table 2 above, shows a significant difference between the secondary healthcare institutions in the provision of VIA requirements for cervical cancer screening. The calculated F-value (6.320) is higher than the critical value of (2.37) at the same degree of freedom and significance level (p) obtained in the test is lower than the fixed level of 0.05 (p < 0.05) The mean is significant at 0.05 level 
Discussion
The researchers examined the availability of visual inspection with acetic acid (VIA) requirement among health workers in secondary healthcare institutions of Kaduna State.
In the course of this study, it has been established that VIA requirements are not available for health workers in the secondary healthcare institutions for cervical cancer screening as indicated in table 1 with an aggregate mean score of (2.1458). one of such basic areas of inadequate VIA requirements in the secondary healthcare institutions were the subjects that agreed that there is no efficient system to ensure that the hospitals do not run out of stock if available. Also there is poor referral system in the hospitals in case of positive cases identified during the screening procedure as indicated in item (7) . To worsen the inadequacy of VIA requirements in the hospitals, the medical equipment stores do not possess the supplies as perceive by the health workers in the study (item 10). These findings are supported by USAID (2010), which stated that cervical cancer screening services with acetic acid staining (VIA) are available only in research settings and/or referral centres of Rwanda, Nigeria and Cote d' Ivore but not available at multiple sites/levels of care throughout the country. Although the study shows that VIA requirements are not present in the hospitals to screen for cervical cancer, it contradicts the statements of Gaffikin, Mcgrath, Arbyn, Blumenthal (2007) whom stated that the pap smear remains the most common screening test for cervical cancer, many developing countries do not have adequate resources to implement cytology based prevention programme. An alternative, low-cost test, visual inspection using acetic acid (VIA), has emerged for use in developing countries, Nigerian inclusive where the resources are available. Even though the VIA requirements are not available in the hospitals, it does not mean that the government cannot afford to provide it in the hospitals in surplus within the state. In the test of the hypothesis stated, a significant difference was observed among the secondary healthcare institution in the provision of VIA requirements for cervical cancer screening, thus the null hypothesis was rejected. USAID (2010) stated that the choice of screening test usually depends on the resources available. Furthermore, many developing countries are now using the single visit approach which combines detection of lesions using visual S/N Secondary healthcare institutions L.G.A Senatorial zone Numbers of nurses inspection with acetic acid followed by immediate treatment if necessary. Therefore, non availability of VIA requirements for screening cervical cancer within the study area encourages development of cervical cancer due to delay in detection of it.
VI.
Conclusion
It can be concluded that VIA requirement are not available in the secondary health care institutions of Kaduna-state.
VII. Recommendation
It is therefore recommended that the hospital management should make provision of VIA requirements through a strategized fund raising so that they can be available in the hospitals in order to tackle delay in detection that could lead to high incidence of cervical cancer.
